NCT01812005 2018-06-06Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaOhio State University Comprehensive Cancer CenterPhase 2 Terminated14 enrolled 11 charts